530125 — Samrat Pharmachem Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.29bn
- IN₹1.48bn
- IN₹3.11bn
- 55
- 20
- 41
- 28
Annual balance sheet for Samrat Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 22.5 | 11.7 | 25.4 | 147 | 119 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 211 | 278 | 330 | 436 | 512 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 328 | 497 | 473 | 713 | 986 |
| Net Property, Plant And Equipment | 68.4 | 82.6 | 93.9 | 99.8 | 107 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 402 | 583 | 574 | 846 | 1,162 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 193 | 339 | 273 | 373 | 528 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 202 | 340 | 278 | 378 | 530 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 201 | 243 | 296 | 468 | 631 |
| Total Liabilities & Shareholders' Equity | 402 | 583 | 574 | 846 | 1,162 |
| Total Common Shares Outstanding |